Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
[11C]-NOP46 PET Imaging in Chronic Pain
NCT03705819Phase 1Completed
- Sponsor
- Columbia University
- Start
- Mar 2019
- Primary completion
- Oct 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label trial of [11C]-NOP46 in chronic pain (2 arms), sponsored by Columbia University. Primary endpoint: Uptake ratio for site with pain at 48 hours. Started Mar 2019; status: completed.
02
Drugs
[11C]-NOP46
03
Conditions
chronic pain
Beyond the preview
Go deeper on NCT03705819.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03705819.